Quantitative high-performance liquid chromatographic method for pharmacokinetic studies of the potent mast cell inhibitor 4-(4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P131)
- 23 April 1999
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 727 (1-2) , 205-212
- https://doi.org/10.1016/s0378-4347(99)00047-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in mice.Pharmaceutical Research, 1999
- Protein tyrosine phosphorylation as a mechanism of signalling in mast cells and basophilsCellular Signalling, 1995
- Early Events in Mast Cell Signal TransductionPublished by S. Karger AG ,1995
- Simultaneous Determination of a Novel Antiarrhythmic Agent, 7-Benzyl-3-Thia-7-Azabicyclo[3.3.1]Nonane and Its Sulfoxidation Metabolite in Plasma and Urine by HPLCJournal of Liquid Chromatography, 1994
- Determination of GLG-V-13, a Novel Antiarrhythmic Agent, in Plasma and Urine by High-Performance Liquid ChromatographyJournal of Liquid Chromatography, 1994
- High-Performance Liquid Chromatographic Determination of SAZ-VII-23, A Novel Antiarrhythmic Agent, in Dog Plasma and UrineAnalytical Letters, 1993
- New Concepts about the Mast CellNew England Journal of Medicine, 1993
- High-Performance Liquid Chromatographic Determination of SAZ-VII-22, a Novel Antiarrhythmic Agent, in Dog Plasma and Urine.Analytical Sciences, 1993
- High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Cytokine production by mast cells and basophilsCurrent Opinion in Immunology, 1991